Symbol="KYMR"
AssetType="Common Stock"
Name="Kymera Therapeutics Inc"
Description="Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system. The company is headquartered in Watertown, Massachusetts."
CIK="1815442"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="300 TECHNOLOGY SQUARE, 2ND FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1088298000"
EBITDA="-170056992"
PERatio="None"
PEGRatio="None"
BookValue="7.93"
DividendPerShare="0"
DividendYield="0"
EPS="-2.66"
RevenuePerShareTTM="0.903"
ProfitMargin="0"
OperatingMarginTTM="-3.333"
ReturnOnAssetsTTM="-0.195"
ReturnOnEquityTTM="-0.378"
RevenueTTM="51669000"
GrossProfitTTM="-117422000"
DilutedEPSTTM="-2.66"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.434"
AnalystTargetPrice="54.88"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="33.3"
PriceToBookRatio="3.168"
EVToRevenue="25.24"
EVToEBITDA="-7.69"
Beta="1.486"
num_52WeekHigh="39.85"
num_52WeekLow="18.53"
num_50DayMovingAverage="21.91"
num_200DayMovingAverage="28.21"
SharesOutstanding="55308000"
DividendDate="None"
ExDividendDate="None"
symbol="KYMR"
open="19.40"
high="19.69"
low="18.95"
price="19.64"
volume="207890.00"
latest_trading_day="2023-08-25"
previous_close="19.35"
change="0.29"
change_percent="1.4987%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="97"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="3"
Volume_recent_avg="464869"
Change_recent_avg="-0.09"
Delta_recent_avg="1.3"
Variance_recent_avg="0.65"
Change_ratio_recent_avg="-0.46"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="3"
Aroon_momentum_negative="97"
image_negative_thumbnail_id_1="150"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0026.jpeg"
image_negative_thumbnail_id_2="92"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_neutral_thumbnail_id_1="531"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0068.jpeg"
image_neutral_thumbnail_id_2="536"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_positive_thumbnail_id_1="674"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0034.jpeg"
image_positive_thumbnail_id_2="985"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0147.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
